Linemen's rapid weight gain can lead to hardening of heart, arteries, but problems may be offset with increased aerobic training
Corrigan Minehan Heart Center
Cardiac Resynchronization Therapy
Explore This Procedure
OverviewPhysicians at the Massachusetts General Hospital Corrigan Minehan Heart Center offer cardiac resynchronization therapy (CRT) or CRT-D (CRT with defibrillator therapy) as an innovative therapeutic option for patients with refractory heart failure. Many patients with heart failure experience an abnormality in the pumping of the heart’s ventricles and need special treatment to synchronize the pumping.
Cardiac resynchronization therapy involves the placement of an implantable biventricular pacing device with three leads (right atrial, right ventricular and left ventricular) that synchronize ventricular contractions. This greatly improves the pumping efficiency of the heart.
Cardiac resynchronization therapy is associated with:
- Improved quality of life
- Increased exercise capacity
- Reduction in hospitalization for heart failure
- Reduction in mortality rates
Cardiac resynchronization therapy has gained widespread acceptance as a safe, effective therapy for qualifying patients with advanced heart failure.
- Jul | 11 | 2019
Whether you're meal-prepping or cooking for a crowd, try out this recipe featuring a healthy combination that does not skip out on flavor.
- Patient Story
- Jun | 28 | 2019
On Dec. 20, 2018, Greenfield, Massachusetts resident and tattoo artist Ben Reigle woke up at 3:50 am and was unable to move the right side of his body.
- Press Release
- Jun | 25 | 2019
A biological pathway previously found to contribute to the impact of stress on the risk of cardiovascular disease also may underlie the increased incidence of such disease experienced by individuals with lower socioeconomic status.
- May | 16 | 2019
Researchers recommend exercise training, alone or in combination with CBT, for patients with heart failure who are experiencing depressive symptoms.
- Press Release
- Mar | 6 | 2019
A team led by Massachusetts General Hospital (MGH) investigators has found that activity of an important signaling pathway increases with aging and with heart failure and that inhibiting that pathway can improve cardiac function in mouse models.